United States · FDA National Drug Code directory
Divalproex sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-821_650146da-3899-4750-8c6e-954ddd19f23a
- Product NDC
- 62332-821
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Divalproex sodium
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241223
- Source listing expiry
- 20271231
Source-listed ingredients
- DIVALPROEX SODIUM — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (62332-821-10) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK · 62332-821-10
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-31) · 62332-821-31
- 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-71) · 62332-821-71
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-91) · 62332-821-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →